IRISYS, LLC Keeping Our Staff Safe During COVID-19

San Diego CA, – April 21, 2020 – IRISYS LLC, as a pharmaceutical manufacturer, is an essential allied healthcare organization plans to remain open during this COVID-19 crisis. We take pride in and value our support of patients who depend on the drugs we produce. Our critical role providing drugs being studied in ongoing clinical trials is a high priority for us. With this in mind, we have taken steps to help ensure that these patients have access to an uninterrupted supply of the high-quality drugs they need.

First and foremost, our number one priority is the health and safety of our employees, their families, and our communities. As a result, we have implemented social distancing in our offices and facility, increased sanitization efforts and implemented a host of other protocols to help protect the well-being of our employees and their loved ones.

We are continuously assessing the situation as we move through this crisis. IRISYS is making every effort to keep our staff in top health during manufacturing and the collaborative process. Our attempts include Restricting visitors to the facility, after entering the building there will be a hand sanitization and mask station set up, meeting room restrictions 10 people limit 6 feet apart, requiring frequent hand washing for at least 20 seconds, and our staff will be sanitizing the office 4 times a day.

As always IRISYS regards the health of our staff and the community as our number one priority and we are dedicated to continuing our mission to improve the public’s health while navigating our way through the COVID-19 pandemic.

Please follow and like us:

Welcome to Societal™
Recro has a new name. And, with it, a renewed sense of what we can accomplish with our partners to expedite the delivery of life-changing pharmaceuticals to patients. Together, we are truly Bringing Science To Society. You will soon be able to explore our vision with the upcoming launch of our new website.